Kris Vaddi is the founder of Prelude Therapeutics. Prelude Therapeutics has raised $95M in total funding. Latest round: Series B. Based in Wilmington, DE.
Krishna ('Kris') Vaddi, Ph.D., is the founder and Chief Executive Officer of Prelude Therapeutics, a clinical-stage biopharmaceutical company focused on developing small molecule cancer drugs. He has served as CEO and a Class III director since February 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library